|XHQLX -- USA Fund|| |
USD 20.98 0.03 0.14%
Mr. Michael W. Bonney is Independent Trustee of HQ Life Sciences Investors., since 2011. Mr. Bonney is the Chief Executive Officer and member of the Board of Directors of Cubist Pharmaceuticals, Inc. until December, 2014, providing each Fund with valuable insight into operating matters relating to biotech companies and the overall healthcare industry. He serves on the Valuation Committee and is Chairman of the Governance and Nominating Committee of each Fund
Age: 58 Executive Since 2011
Bonney is also a Director of Alnylam Pharmaceuticals, Inc. and is Chairman of the Board of Trustees of Bates College. He holds a BA degree from Bates College.